Amerika Serikat - Inggris - NLM (National Library of Medicine)

wisconsin pharmacal company - borax 3x hpus, collinsonia canadensis 3x hpus, berberis vulgaris 6x hpus, hamamelis virginiana 6x hpus - purpose temporary relief from external vagianl discomfort including itching, burning, and irritation uses for temporary relief of symptoms associate with vaginal yeast infection, including:itching, burning, and irritation.

Filipina - Inggris - FDA (Food And Drug Administration)

elanco philippines, inc; distributor: elanco philippines, inc - multivitamins , minerals , amino acid , nucleotides , yeast extract , evening primrose oil (vet.) - oral solution - formulation: each liter contains: retinyl propionate (vitamin a) 500,000, iu cholecalciferol (vitamin d3) 75,000, iu c-tocopheryl acetate (vitamin e) 10g, niacin 1.4g thiamine, (vitamin bi) 1.25 g, ascorbic acid (vitamin c) 1g, pyridoxine (vitamin b6) 625 mg, folic acid 625 mg, riboflavin (vitamin b2) 500 mg, vitamin k 350 mg, cyanocobalamin (vitamin b12) 5.3mg, biotin (vitamin h) 1.5 mg, zinc 3g, copper 2 g, manganese 1g, iodine (potassium lodide) 500 mg, cobalt 500 mg, magnesium sulfate heptahydrate 455 mg, selenium 125 mg, potassium chloride 82.43 g, sodium chloride 9.815 g, citric acid 3.28 g, methionine 1.5 g, lysine 1g, nucleotides 5g, yeast extract 1g, evening primrose oil 500 mg

Filipina - Inggris - FDA (Food And Drug Administration)

elanco philippines, inc.; distributor: elanco philippines, inc. - multivitamins , minerals , amino acid , nucleotides , yeast extract , evening primrose oil (vet.) - oral gel - each kilogram contains: retinol propionate (vitamin a) 5,000, iu cholecalciferol (vitamin d3) 750, iu tocopherol (vitamin e) 100 mg, niacin (vitamin b3) 14 mg, thiamine (vitamin b1) 12.5 mg, ascorbic acid (vitamin c 10 mg pyridoxine (vitamin b6 6.25, mg pantothenic acid (vitamin b5) 6.25 mg, folic acid (vitamin b9) riboflavin, (vitamin b2 5 mg, cyanocobalamin (vitamin b12) 53 mcg, biotin 12.5 mcg, copper 20 mg , manganese 10 mg, cobalt 5 mg, lodine 5 mg, selenium 1.25 mg, methionine 15 mg, lysine 10 mg, potassium chloride 824 mg, citric acid 125 mg, sodium chloride 98 mg, magnesium sulfate heptahydrate 4.6 mg, nucleotides 50 mg, yeast extract 10 mg, evening primrose oil 5 mg

Filipina - Inggris - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - multivitamins , hydrolyzed yeast (vet.) - oral solution - formulation: each 1 l contains: nicotinamide (vitamin b3) ...................... 16.25 g dexpanthenol (vitamin b5) ..................... 7.5 g thiamine hydrochloride (vitamin b1) ...... 1.75 g riboflavin (vitamin b2) ......... 2.5 g pyridoxine hydrochloride (vitamin b6) ....... 1.125 g inositol .......... ......... 2.5 g biotin (vitamin b7) ............... 1 mg hydrolyzed yeast ................. 470 ml

Israel - Inggris - Ministry of Health

bayer israel ltd - levonorgestrel - intrauterine delivery system - levonorgestrel 13.5 mg - levonorgestrel - contraception for up to 3 years.

Israel - Inggris - Ministry of Health

bayer israel ltd - levonorgestrel - intrauterine delivery system - levonorgestrel 13.5 mg - levonorgestrel - contraception for up to 3 years.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - levonorgestrel, quantity: 19.5 mg - drug delivery system, intrauterine - excipient ingredients: dimethylsiloxane/methylvinylsiloxane cross linked elastomer - contraception for up to 5 years

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ustekinumab, quantity: 45 mg - injection, solution - excipient ingredients: histidine; polysorbate 80; histidine hydrochloride monohydrate; water for injections; sucrose - plaque psoriasis,adults - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.,paediatric population, 6 years and older - stelara is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from 6 years of age who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.,psoriatic arthritis (psa),stelara, alone or in combination with methotrexate, is indicated for the treatment of signs and symptoms of active psoriatic arthritis in adult patients (18 years and older) where response to previous non-biological dmard therapy has been inadequate.,crohn?s disease,stelara is indicated for the treatment of adult patients with moderately to severely active crohn?s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a tnf alpha antagonist or have medical contraindications to such therapies.,ulcerative colitis,stelara is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pravastatin sodium, quantity: 40 mg - tablet, uncoated - excipient ingredients: lactose; sodium stearylfumarate; iron oxide yellow - 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg; poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. cholvastin is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/l) serum cholesterol levels. 3. cholvastin is indicated in patients with unstable angina pectoris see clinical trials). 4. cholvastin is also indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years of age or older (see clinical trials). 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg; poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. vastoran is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/l) serum cholesterol levels. 3. vastoran is indicated in patients with unstable angina pectoris see clinical trials). 4. vastoran is also indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years of age or older (see clinical trials).

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pravastatin sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: lactose; sodium stearylfumarate; iron oxide yellow - 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg; poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. cholvastin is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/l) serum cholesterol levels. 3. cholvastin is indicated in patients with unstable angina pectoris see clinical trials). 4. cholvastin is also indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years of age or older (see clinical trials). 1. as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (eg; poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. 2. vastoran is indicated in patients with previous myocardial infarction including those who have normal (4.0 - 5.5 mmol/l) serum cholesterol levels. 3. vastoran is indicated in patients with unstable angina pectoris see clinical trials). 4. vastoran is also indicated as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years of age or older (see clinical trials).